EyePoint Inc reports results for the quarter ended June 30 - Earnings Summary

EyePoint

05/08/2026 13:49

EyePoint Inc EYPT.OQ reported a quarterly adjusted loss of $1.09​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -85 cents.  The mean expectation of fourteen analysts for the quarter was for a loss of 95 cents per share. Wall Street expected results to range from $-1.20 to -77 cents per share.
Revenue fell 90.5% to $507.00 thousand from a year ago; analysts expected $406.86 thousand. 
EyePoint Inc's reported EPS for the quarter was a loss of $1.09​.
The company reported a quarterly loss of $94.47 million.
EyePoint Inc shares had fallen by 18.4% this quarter and lost 36.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 6.2% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy" 
Wall Street's median 12-month price target for EyePoint Inc is $39.00, about 70.1% above its last closing price of $11.67
This summary was machine generated from LSEG data August 5 at 12:49 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.95
-1.09
Missed
Mar. 31 2026 
-0.81
-0.99
Missed
Dec. 31 2025 
-0.75
-0.81
Missed
Sep. 30 2025 
-0.78
-0.85
Missed